Cardiology

Outline a new standard for pharmacologic management of patients with HFrEF using four key drug classes.

Report estimates that more than 130,000 Canadians with undiagnosed chronic diseases did not begin treatment in 2020.

Cases of cardiac arrhythmias possibly associated with the use of oral Ginkgo biloba-containing products have been reported in Canada and internationally.

With cardiovascular disease being a leading cause of death among elderly early breast cancer survivors, there is motivation to reduce the risk of cardiotoxicity. Statins have emerged as a promising candidate.

Thrombosis Canada issues statement covering warfarin, DOACs and antiplatelet agents.

Two studies show LDL lowering significantly reduces the risk of major vascular events in older patients.

Designed to help improve clinical management of an important and challenging arrhythmia.